{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that wild-type LRRK2 enhances stress tolerance via ERK pathway activation, while mutants (Y1699C/G2019S) lose this protective function, making cells vulnerable to oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism (loss of stress protection via MAPK/ERK pathways) is explicitly defined in the paper."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "The study uses H2O2-induced oxidative stress assays in HEK293 and SH-SY5Y cells to assess stress tolerance, directly linked to LRRK2's proposed role in stress response.",
          "judgment": "Yes",
          "reasoning": "Oxidative stress assays are a well-established method to model stress response pathways, aligning with the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances",
          "assessment_steps": [
            {
              "step_name": "Sub-step 3a: Basic Controls and Replicates",
              "extracted_paper_info": "Wild-type LRRK2 is compared to Y1699C and G2019S mutants in HEK293 and SH-SY59Y cells. Replicates are implied but not explicitly quantified.",
              "judgment": "Insufficient",
              "reasoning": "While wild-type serves as a control, the paper does not detail statistical replicates or confirm abnormal/pathogenic controls."
            },
            {
              "step_name": "Sub-step 3b: Accepted/Validated Assay",
              "extracted_paper_info": "The oxidative stress assay is referenced in prior studies (Jain et al., 2005; West et al., 2005), validating its use for stress response pathways.",
              "judgment": "Yes",
              "reasoning": "The assay is a standard method in stress response research, confirmed by cited literature.",
              "next_step_or_outcome": "Max PS3_supporting / Max BS3_supporting"
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "assessment_steps": [
            {
              "step_name": "Sub-step 4a: Statistical Analyses",
              "extracted_paper_info": "No p-values, effect sizes, or OddsPath calculations are explicitly reported.",
              "judgment": "No",
              "reasoning": "Statistical details are absent, preventing OddsPath estimation.",
              "next_step_or_outcome": "Proceed to Sub-step 4b"
            },
            {
              "step_name": "Sub-step 4b: No OddsPath Calculation",
              "extracted_paper_info": "The study compares wild-type vs. two mutants (Y1699C and G2019S). Total controls (wild-type, Y1699C, G2019S) = 3.",
              "judgment": "10 or less",
              "reasoning": "With 3 total controls, the evidence strength is capped at Max PS3_supporting.",
              "next_step_or_outcome": "Final strength: PS3_supporting"
            }
          ]
        }
      ],
      "final_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that wild-type LRRK2 enhances stress tolerance via ERK pathway activation, while mutants (Y1699C/G2019S) lose this protective function, making cells vulnerable to oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism (loss of stress protection via MAPK/ERK pathways) is explicitly defined in the paper."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "The study uses H2O2-induced oxidative stress assays in HEK293 and SH-SY5Y cells to assess stress tolerance, directly linked to LRRK2's proposed role in stress response.",
          "judgment": "Yes",
          "reasoning": "Oxidative stress assays are a well-established method to model stress response pathways, aligning with the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances",
          "assessment_steps": [
            {
              "step_name": "Sub-step 3a: Basic Controls and Replicates",
              "extracted_paper_info": "Wild-type LRRK2 is compared to Y1699C and G2019S mutants in HEK293 and SH-SY59Y cells. Replicates are implied but not explicitly quantified.",
              "judgment": "Insufficient",
              "reasoning": "While wild-type serves as a control, the paper does not detail statistical replicates or confirm abnormal/pathogenic controls."
            },
            {
              "step_name": "Sub-step 3b: Accepted/Validated Assay",
              "extracted_paper_info": "The oxidative stress assay is referenced in prior studies (Jain et al., 2005; West et al., 2005), validating its use for stress response pathways.",
              "judgment": "Yes",
              "reasoning": "The assay is a standard method in stress response research, confirmed by cited literature.",
              "next_step_or_outcome": "Max PS3_supporting / Max BS3_supporting"
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "assessment_steps": [
            {
              "step_name": "Sub-step 4a: Statistical Analyses",
              "extracted_paper_info": "No p-values, effect sizes, or OddsPath calculations are explicitly reported.",
              "judgment": "No",
              "reasoning": "Statistical details are absent, preventing OddsPath estimation.",
              "next_step_or_outcome": "Proceed to Sub-step 4b"
            },
            {
              "step_name": "Sub-step 4b: No OddsPath Calculation",
              "extracted_paper_info": "The study compares wild-type vs. two mutants (Y1699C and G2019S). Total controls (wild-type, Y1699C, G2019S) = 3.",
              "judgment": "10 or less",
              "reasoning": "With 3 total controls, the evidence strength is capped at Max PS3_supporting.",
              "next_step_or_outcome": "Final strength: PS3_supporting"
            }
          ]
        }
      ],
      "final_strength": "PS3_supporting"
    }
  ]
}